Welcome to the Full -Year Results Press Conference

Similar documents
Welcome to the Nine-Month Sales Conference

Key figures (consolidated)

Expanding the boundaries of nutrition Luis Cantarell

Nutrition, Health & Wellness The Nestlé Perspective. Paul Bulcke Chief Executive

Welcome to the New York Press Conference

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

Nestlé Dairy s new frontier: healthy ageing

Nestlé Investor Seminar 2008

Autumn Press Conference October 2005

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Investor Day Lausanne, September 29, Nicholas Rolli Vice President, Investor Relations & Financial Communications

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Nestlé Public Health Nutrition

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO

WELCOME TO ACTELION S AGM 2015

DuPont Nutrition & Health Craig Binetti, President

Shaping the Future. Nestlé Research World-Wide. Werner Bauer. Chief Technology Officer

Nestlé Health Science Overview

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Harm de Wildt MD TNI

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

PACKAGING: A KEY DRIVER FOR HEALTHIER CONSUMPTION

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

DSM Capital Markets Day 2018

Nestlé Investor Seminar 2007

Investor Presentation

BALCHEM CORPORATION. Q Investor Relations Presentation

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

Building a new model of sustainable chemistry. Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Slide 1. Investor presentation. London 5 February 2019

Putting ALK on the right growth trajectory

A world leader in allergy immunotherapy

The acquisition of Fortitech

Cochlear Limited 2017 Annual General Meeting Chairman s Address

January 30, 2018 Dow Wilson President and Chief Executive Officer

Consolidated: Financial Summary

Imperial Brands Maximising Category Opportunities CAGNY February 2019

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Third-quarter results 2013

JT Group Consolidated Financial Results 2018 First Quarter Results

HILLENBRAND INDUSTRIES INC

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Letter to Shareholders SEMI-ANNUAL REPORT 2008

The Global Alliance for Improved Nutrition

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

Slide 1. Investor presentation. Copenhagen 1 November 2018

RISK ALLOCATION IN TRANSPORTATION INFRASTRUCTURE PROJECTS

Nestlé in the USA & Frozen Meals Performance. February 23, 2017 Jeff Hamilton President Nestlé Food Division Nestlé USA

Dr. Manfred Eggersdorfer Senior Vice President Research & Development DSM Nutritional Products

Summary Statement of Financial Position (consolidated)

Roche Diagnostics Daniel O Day COO Roche Diagnostics. Société Générale - The Premium Review Conference, Paris December 2, 2011

Lars Dahlgren. President and CEO

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

Country Coverage. Company Coverage

JP Morgan 2011 Healthcare Conference. David Redfern, Chief Strategy Officer 12 January 2011

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

For personal use only

Nutrition Chris Goppelsroeder President & CEO DSM Nutritional Products ROYAL DSM HEALTH NUTRITION MATERIALS

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

FOCUSED ON QUALITY GROWTH

For personal use only

TELECONFERENCE FY February 2015

Reynolds American to Acquire Lorillard

Continued value growth

Company presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018

Development Bank of Southern Africa Amendment Bill [B ]

Slide 1. Winning with GLP-1. Lars Fruergaard Jørgensen President and CEO. ALEXANDRE DE GREGORIO, Brazil Alexandre has type 2 diabetes

Key figures by management responsibility and geographic area

Value growth in Human Nutrition & Health

FIRSTQUARTER2018 RESULTSPRESENTATION

Roche Diagnostics. Daniel O Day COO Roche Diagnostics. Vontobel Summer Conference June 22, 2012

Forward Looking Information

For personal use only

The Case for Flour Fortification

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Dynamic Growth. Investora Gerhard Mahrle CFO COLTENE Holding AG. September 2018

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

Efforts start to pay off in the fourth quarter

MEDICAL CANNABIS COMPANY

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

For personal use only

Forward-Looking Statements

Singapore Press Holdings. 1Q FY12 Financial Results 10 January 2012

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Influence of healthy eating on market trends. Paul Paquin, Ph.D. INAF, Université Laval, Québec

PROACTIVE INVESTOR PRESENTATION

Solvay expands its specialty polymers offerings with Ryton PPS acquisition

4 th Quarter 2017 Earnings Review & Investor Update

ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference

DELICA D:5 ACTIVE GEAR 0

Transcription:

Welcome to the Full -Year Results Press Conference

Disclamer This presentation contains forward looking statements which reflect Management s current views and estimates. The forward looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures and regulatory developments.

Full -Year Results Press Conference Paul Bulcke Nestlé CEO

Executive Board Paul Bulcke Werner Bauer Luis Cantarell José Lopez John J. Harris Laurent Freixe Chris Johnson Patrice Bula Nandu Nandkishore Wan Ling Martello Marc Caira Jean-Marc Duvoisin David Frick 3

Good performance across the board Agenda Embracing Nutrition, Health and Wellness Investing for the future Q&A 4

Good performance across the board Agenda Embracing Nutrition, Health and Wellness Investing for the future Q&A 5

Full -Year Results Press Conference Wan Ling Martello Chief Financial Officer

2012 Commitments Financial Efficiencies Strategic Delivered the Nestlé Model Sustainable dividend policy CHF 1.5 bn+ SKUs -14% Capital efficiencies Delivering in 2012; investing for the future 7

2012 Results Overview Sales CHF 92.2 bn Trading Operating Profit CHF 14.0 bn Cash Flow CHF 15.8 bn +CHF 8.6 bn +CHF 1.5 bn +CHF 5.6 bn +5.9% OG 15.2% +55% +3.1% RIG +20 bps Delivering the Nestlé Model 8

Americas Europe Asia, Oceania & Africa Sales (CHF) OG 41 bn +5.9% 26 bn +2.4% 25 bn +10.3% RIG +1.8% +1.5% +7.5% * Each region includes Zones, Nestlé Waters, Nestlé Nutrition, Nestlé Professional, Nespresso, NHSc and JVs; OG = Organic Growth, RIG = Real Internal growth 9

Marketing Spend +30 bps Billionaire Brands +7% OG OG figure excludes Yinlu, Hsu Fu Chi and Wyeth Nutrition 10

Delivered in 2012; well set for 13 & beyond Delivered Organic growth and TOP margin improvement Increased EPS and Cash flow Grew in Emerging and Developed markets Grew in PPPs and Premium Investing in our brands and routes to market Creating value for society and shareholders Nestlé Model reconfirmed for 2013 11

Full -Year Results Press Conference Paul Bulcke Nestlé CEO

Good performance across the board Agenda Embracing Nutrition, Health and Wellness Investing for the future Q&A 13

Our ambition The world s leading nutrition, health and wellness company A reference for financial performance Trusted by all stakeholders 14

Enhancing the quality of life Our Nutrition, Health & Wellness strategy with good food and beverages everywhere with personalised nutrition for medical conditions 15

Nutrition, Health and Wellness is all about Products Communication Linking up with society 16

Products Innovating and renovating our portfolio year on year 1/3 of portfolio per year CHF 32 billion sales in 2012 17

VIT A ZINC IRON IODINE Products Fortifying our products with micro-nutrients Iron deficient anemia in pre-school children Iodine deficiency in school children Vitamin A deficiency in pre-school children Risk of zinc deficiency in population 18

Products Fortifying our products with micro-nutrients 160 billion servings per year 19

Products Reducing the levels of public health-sensitive nutrients 20

Communication Helping our consumers make informed choices 21

Linking Linking up up with society with society Being part of the solution 22

Good performance across the board Agenda Embracing Nutrition, Health and Wellness Investing for the future Q&A 23

R&D Strengthening our R&D capabilities 34 Nestlé R&D Centres Over 5,000 people directly involved in R&D 24

Nestlé Health Science Expanding the boundaries of nutrition 25

Mergers & and Acquisitions Acquisitions Enhancing our global infant nutrition business 26

Nestlé: uniquely positioned for profitable growth 27

Good performance across the board Agenda Embracing Nutrition, Health and Wellness Investing for the future Q&A 28

29